PHAT — Phathom Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapNeutral

Annual balance sheet for Phathom Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	183	155	381	297	130
Net Total Accounts Receivable
Net Total Receivables	—	—	1.64	38.8	78.1
Total Inventory
Prepaid Expenses
Total Current Assets	187	161	397	360	229
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.56	3.49	3.62	2.09	3.67
Other Long Term Assets
Total Assets	189	165	414	378	259
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	18.9	26.2	38.8	85.7	132
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	117	240	487	632	697
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	72.2	-74.8	-72.8	-254	-438
Total Liabilities & Shareholders' Equity	189	165	414	378	259
Total Common Shares Outstanding